IL6 and Decreased liver function: In previous studies, we had shown that liver inflammation induced by T/HS is associated with liver dysfunction and 72% mortality [12], [29], and IL-6 administration at the start of resuscitation completely reversed T/HS-induced liver inflammation and injury, decreasing mortality 5-fold, to 15% [12], [29].